dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Mota Jimenez, Alba |
dc.contributor.author | Oltra, Sara S |
dc.contributor.author | Selenica, Pier |
dc.contributor.author | Moiola, Cristian Pablo |
dc.contributor.author | Casas-Arozamena, Carlos |
dc.contributor.author | Lopez Gil, Carlos |
dc.contributor.author | Rojo Sebastian, Alejandro |
dc.contributor.author | Colas Ortega, Eva |
dc.contributor.author | Gil Moreno, Antonio |
dc.date.accessioned | 2022-08-19T09:33:44Z |
dc.date.available | 2022-08-19T09:33:44Z |
dc.date.issued | 2022-03-25 |
dc.identifier.citation | Mota A, Oltra SS, Selenica P, Moiola CP, Casas-Arozamena C, López-Gil C, et al. Intratumor genetic heterogeneity and clonal evolution to decode endometrial cancer progression. Oncogene. 2022 Mar 25;41:1835–50. |
dc.identifier.issn | 1476-5594 |
dc.identifier.uri | https://hdl.handle.net/11351/8023 |
dc.description | Càncer d'endometri; Evolució clonal; Mutació |
dc.description.sponsorship | We thank all those at the Translational Research Laboratory of the MD Anderson Cancer Center Madrid for their invaluable help with this study. Tissue samples were obtained with the support of the MD Anderson Foundation Biobank (record number B.0000745, ISCIII National Biobank Record), the “Xarxa Catalana de Bancs de Tumors” and “Plataforma de Biobancos” ISCIII (PT13/0010/0014, B.000609). This study has been supported by the Spanish Ministry of Economy and Innovation (PID2019-104644RB-I00 (GMB), the Instituto de Salud Carlos III (ISCIII, CIBERONC, CB16/12/00295 - GMB-, CB16/12/00328 -EC, AGM- and CB16/12/00231 -XMG- [all partly supported by FEDER funds]) and by the AECC Scientific Foundation (FC_AECC PROYE19036MOR -GMB- and Coordinated groups 2018 -XMG, AGM, GMB-). SO is funded by an AECC-postdoctoral grant (2020). JSR-F and BW are funded in part by the Breast Cancer Research Foundation and in part by the NIH/NCI P50 CA247749 01 grant. Research reported in this publication was supported in part by a Cancer Center Support Grant of the NIH/NCI (Grant No. P30CA008748; MSK). We thank the Eurofins Megalab laboratory for helping us to perform the analysis of DNA HPV detection. |
dc.language.iso | eng |
dc.publisher | Springer Nature |
dc.relation.ispartofseries | Oncogene;41 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Endometri - Càncer - Aspectes genètics |
dc.subject.mesh | Endometrial Neoplasms |
dc.subject.mesh | /genetics |
dc.subject.mesh | Genetic Heterogeneity |
dc.title | Intratumor genetic heterogeneity and clonal evolution to decode endometrial cancer progression |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1038/s41388-022-02221-0 |
dc.subject.decs | neoplasias endometriales |
dc.subject.decs | /genética |
dc.subject.decs | heterogeneidad genética |
dc.relation.publishversion | https://doi.org/10.1038/s41388-022-02221-0 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Mota A] MD Anderson International Foundation, Madrid, Spain. Biochemistry Department, Universidad Autónoma de Madrid (UAM), Instituto de Investigaciones Biomédicas ‘Alberto Sols’ (CSIC-UAM), IdiPaz, Madrid, Spain. [Oltra SS] MD Anderson International Foundation, Madrid, Spain. Biochemistry Department, Universidad Autónoma de Madrid (UAM), Instituto de Investigaciones Biomédicas ‘Alberto Sols’ (CSIC-UAM), IdiPaz, Madrid, Spain. Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. [Selenica P] Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, USA. [Moiola CP, Colas E] Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. Grup de Recerca Biomèdica en Ginecologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Casas-Arozamena C] Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago de Compostela (IDIS), University Hospital of Santiago de Compostela (SERGAS), Santiago de Compostela, Spain. [López-Gil C] Grup de Recerca Biomèdica en Ginecologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Rojo-Sebastián A] Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. Grup de Recerca Biomèdica en Ginecologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. MD Anderson Cancer Center, Madrid, Spain. [Gil-Moreno A] Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. Grup de Recerca Biomèdica en Ginecologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Servei de Ginecologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 35145232 |
dc.identifier.wos | 000754012300003 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |